Pre-radiotherapy PSA progression is a negative prognostic factor in prostate cancer patients using 5‑alpha-reductase inhibitors
ConclusionPSA progression experienced during 5 ‑ARI treatment before radiotherapy is predictive of worse biochemical outcome. Such details should be considered when counseling men prior to radiation therapy.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | Databases & Libraries | External Beam Therapy | Prostate Cancer | Radiation Therapy